Evidence map›Paper›PMID 35668753›Full record

ArticleFrontiers in microbiology2022

Production and Characterization of Exopolysaccharide From Newly Isolated Marine Probiotic

Eman H Zaghloul, Mohamed I A Ibrahim

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Evaluation of the Safety and Impact of Heat-TreatedJournal of microbiology and biotechnology · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Isolation andFrontiers in microbiology · 2026
    Article
  9. Neuroprotective role ofFrontiers in nutrition · 2026
    Article
  10. Exopolysaccharides from lactic acid bacteria: functional ingredients with biotechnological potential - a critical review.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eman H ZaghloulNational Institute of Oceanography and Fisheries, NIOF, Egypt.
Mohamed I A IbrahimNational Institute of Oceanography and Fisheries, NIOF, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of its safety, biological activities, and unique properties, exopolysaccharide (EPS) from lactic acid bacteria (LAB) has been developed as a potential biopolymer. A few studies have investigated the EPS produced by marine LAB. This study reports the wound healing activity of an EPS produced by a marine isolate identified as

Indexed as

chemical characterizationexopolysaccharideLactiplantibacillusprobioticswound healing

Identifiers

PMID35668753
PMCPMC9164304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.